LODH Immunology Fund
Europe, Geneve, Switzerland, Geneva
Description
The LODH Immunology Fund is a Swiss open-ended mutual fund managed by Lombard Odier Darier Hentsch & Cie, a Swiss private bank.
Investor Profile
LODH Immunology Fund has backed more than 6 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 17% of its total and boasts 2 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series Unknown, Series B rounds (top funding stages).
- Majority of deals are located in Switzerland, Denmark.
- Strong thematic focus on Biotechnology, Medical, Health Care.
Stage Focus
- Series A (50%)
- Series Unknown (33%)
- Series B (17%)
Country Focus
- Switzerland (67%)
- Denmark (33%)
Industry Focus
- Biotechnology
- Medical
- Health Care
- Pharmaceutical
- Therapeutics
- Manufacturing
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
